$BLD
TopBuild Corp

2024 Q3 Form 10-Q Financial Statement

#000155837024011080 Filed on August 06, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $1.373B $1.366B
YoY Change 3.56% 3.67%
Cost Of Revenue $951.5M $941.7M
YoY Change 5.08% 5.16%
Gross Profit $421.8M $423.9M
YoY Change 0.27% 0.5%
Gross Profit Margin 30.72% 31.04%
Selling, General & Admin $177.8M $213.5M
YoY Change -2.94% 16.3%
% of Gross Profit 42.16% 50.37%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $35.49M $35.03M
YoY Change 5.93% 7.62%
% of Gross Profit 8.41% 8.26%
Operating Expenses $177.8M $213.5M
YoY Change -2.94% 16.3%
Operating Profit $244.0M $210.4M
YoY Change 2.74% -11.68%
Interest Expense -$18.45M -$18.57M
YoY Change -197.98% 0.05%
% of Operating Profit -7.56% -8.83%
Other Income/Expense, Net -$16.09M -$7.218M
YoY Change 25.59% -256.74%
Pretax Income $227.9M $203.2M
YoY Change 1.43% -8.95%
Income Tax $58.94M $52.45M
% Of Pretax Income 25.86% 25.82%
Net Earnings $169.0M $150.7M
YoY Change 0.81% -8.32%
Net Earnings / Revenue 12.3% 11.04%
Basic Earnings Per Share $5.68 $4.81
Diluted Earnings Per Share $5.65 $4.78
COMMON SHARES
Basic Shares Outstanding 30.17M 31.82M
Diluted Shares Outstanding 29.93M 31.52M

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $257.3M $463.2M
YoY Change -58.2% -11.99%
Cash & Equivalents $257.3M $463.2M
Short-Term Investments
Other Short-Term Assets $43.81M $43.55M
YoY Change 14.99% 70.41%
Inventory $392.2M $393.8M
Prepaid Expenses
Receivables $827.8M $859.7M
Other Receivables $0.00 $0.00
Total Short-Term Assets $1.521B $1.760B
YoY Change -19.17% -1.91%
LONG-TERM ASSETS
Property, Plant & Equipment $459.2M $458.6M
YoY Change -3.19% -0.91%
Goodwill $2.092B $2.091B
YoY Change 2.58% 4.96%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $12.46M $10.19M
YoY Change 10.27% -21.06%
Total Long-Term Assets $3.129B $3.143B
YoY Change -0.09% 2.59%
TOTAL ASSETS
Total Short-Term Assets $1.521B $1.760B
Total Long-Term Assets $3.129B $3.143B
Total Assets $4.651B $4.903B
YoY Change -7.25% 0.93%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $461.5M $461.1M
YoY Change 1.24% -1.59%
Accrued Expenses $229.9M $211.7M
YoY Change -0.59% -6.34%
Deferred Revenue $17.95M $15.98M
YoY Change 9.31% -2.15%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $45.14M $45.67M
YoY Change -6.08% -3.5%
Total Short-Term Liabilities $756.1M $752.2M
YoY Change 0.33% -0.8%
LONG-TERM LIABILITIES
Long-Term Debt $1.341B $1.352B
YoY Change -3.06% -3.38%
Other Long-Term Liabilities $1.434M $1.422M
YoY Change -7.36% -99.31%
Total Long-Term Liabilities $1.343B $1.353B
YoY Change -3.06% -15.77%
TOTAL LIABILITIES
Total Short-Term Liabilities $756.1M $752.2M
Total Long-Term Liabilities $1.343B $1.353B
Total Liabilities $2.536B $2.546B
YoY Change -2.69% -2.83%
SHAREHOLDERS EQUITY
Retained Earnings $2.843B $2.674B
YoY Change 27.8% 30.0%
Common Stock $923.4M $919.7M
YoY Change 2.44% 2.63%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.114B $2.357B
YoY Change
Total Liabilities & Shareholders Equity $4.651B $4.903B
YoY Change -7.25% 0.93%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income $169.0M $150.7M
YoY Change 0.81% -8.32%
Depreciation, Depletion And Amortization $35.49M $35.03M
YoY Change 5.93% 7.62%
Cash From Operating Activities $240.7M $90.35M
YoY Change 18.73% -58.17%
INVESTING ACTIVITIES
Capital Expenditures $20.82M $16.09M
YoY Change 19.66% 6.63%
Acquisitions
YoY Change
Other Investing Activities -$151.0K -$65.34M
YoY Change -99.83% -29270.09%
Cash From Investing Activities -$20.97M -$81.43M
YoY Change -80.07% 447.71%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -425.8M -514.9M
YoY Change 5289.27% 5673.17%
NET CHANGE
Cash From Operating Activities 240.7M 90.35M
Cash From Investing Activities -20.97M -81.43M
Cash From Financing Activities -425.8M -514.9M
Net Change In Cash -206.1M -505.9M
YoY Change -329.97% -363.22%
FREE CASH FLOW
Cash From Operating Activities $240.7M $90.35M
Capital Expenditures $20.82M $16.09M
Free Cash Flow $219.9M $74.26M
YoY Change 18.65% -63.04%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Accrued Insurance Noncurrent
AccruedInsuranceNoncurrent
58783000
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
132529000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
146213000
CY2024Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
3318000
CY2023Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
4150000
CY2024Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1422000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1554000
CY2024Q2 us-gaap Liabilities
Liabilities
2545679000
CY2023Q4 us-gaap Liabilities
Liabilities
2599196000
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
39561321
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
30584176
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
39492037
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31776039
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
396000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
394000
CY2024Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
8977145
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
7715998
CY2024Q2 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
1215829000
CY2023Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
699327000
CY2024Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
919317000
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
906334000
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2674023000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2370919000
CY2024Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-20593000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-14665000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
2357314000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
2563655000
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4902993000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5162851000
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1365612000
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1317262000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2644329000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2582500000
CY2024Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
941690000
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
895462000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1833257000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1790485000
CY2024Q2 us-gaap Gross Profit
GrossProfit
423922000
CY2023Q2 us-gaap Gross Profit
GrossProfit
421800000
us-gaap Gross Profit
GrossProfit
811072000
us-gaap Gross Profit
GrossProfit
792015000
CY2024Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
213530000
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
184697000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
386172000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
355481000
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
210392000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
237103000
us-gaap Operating Income Loss
OperatingIncomeLoss
424900000
us-gaap Operating Income Loss
OperatingIncomeLoss
436534000
CY2024Q2 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
18568000
CY2023Q2 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
18558000
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
37363000
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
36597000
CY2024Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
11350000
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4605000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
22632000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
6528000
CY2024Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-7218000
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-13953000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-14731000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-30069000
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
203174000
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
223150000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
410169000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
406465000
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
52451000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
58750000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
107065000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
106195000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
150723000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
164400000
us-gaap Net Income Loss
NetIncomeLoss
303104000
us-gaap Net Income Loss
NetIncomeLoss
300270000
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.81
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
5.20
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
9.63
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
9.51
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.78
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
5.18
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
9.56
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
9.47
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31324833
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31599744
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31483144
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31575337
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31524063
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31731807
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31693524
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31722660
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
150723000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
164400000
us-gaap Net Income Loss
NetIncomeLoss
303104000
us-gaap Net Income Loss
NetIncomeLoss
300270000
CY2024Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-1836000
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
4283000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-5928000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
6037000
CY2024Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
148887000
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
168683000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
297176000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
306307000
us-gaap Profit Loss
ProfitLoss
303104000
us-gaap Profit Loss
ProfitLoss
300270000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
69291000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
64652000
us-gaap Share Based Compensation
ShareBasedCompensation
9759000
us-gaap Share Based Compensation
ShareBasedCompensation
6886000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
131000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-621000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1440000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1440000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
9874000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
4031000
us-gaap Inventory Write Down
InventoryWriteDown
4892000
us-gaap Inventory Write Down
InventoryWriteDown
3290000
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
dei Entity Central Index Key
EntityCentralIndexKey
0001633931
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-36870
dei Entity Registrant Name
EntityRegistrantName
TopBuild Corp
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-3096382
dei Entity Address Address Line1
EntityAddressAddressLine1
475 North Williamson Boulevard
dei Entity Address City Or Town
EntityAddressCityOrTown
Daytona Beach
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
32114
dei City Area Code
CityAreaCode
386
dei Local Phone Number
LocalPhoneNumber
304-2200
dei Security12b Title
Security12bTitle
Common stock, par value $0.01 per share
dei Trading Symbol
TradingSymbol
BLD
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
30166212
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
463221000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
848565000
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
22718000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
23948000
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
859725000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
799009000
CY2024Q2 us-gaap Inventory Net
InventoryNet
393810000
CY2023Q4 us-gaap Inventory Net
InventoryNet
364731000
CY2024Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
43550000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
36939000
CY2024Q2 us-gaap Assets Current
AssetsCurrent
1760306000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
2049244000
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
191048000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
204629000
CY2024Q2 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
267523000
CY2023Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
264487000
CY2024Q2 us-gaap Goodwill
Goodwill
2090788000
CY2023Q4 us-gaap Goodwill
Goodwill
2042568000
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
583141000
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
591058000
CY2024Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
10187000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
10865000
CY2024Q2 us-gaap Assets
Assets
4902993000
CY2023Q4 us-gaap Assets
Assets
5162851000
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
461139000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
469585000
CY2024Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
45665000
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
47039000
CY2024Q2 bld Accrued Liabilities And Employee Related Liabilities Current
AccruedLiabilitiesAndEmployeeRelatedLiabilitiesCurrent
176753000
CY2023Q4 bld Accrued Liabilities And Employee Related Liabilities Current
AccruedLiabilitiesAndEmployeeRelatedLiabilitiesCurrent
187217000
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
66953000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
65780000
CY2024Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1739000
CY2023Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1917000
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
752249000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
771538000
CY2024Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1351969000
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1373028000
CY2024Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
243790000
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
243930000
CY2024Q2 us-gaap Accrued Insurance Noncurrent
AccruedInsuranceNoncurrent
60402000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
58411000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
37247000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
30758000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-54623000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
6595000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-8897000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-17480000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-8806000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-13348000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-13872000
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-2509000
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
1012000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
269128000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
385797000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
35974000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
30672000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
88123000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
45948000
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
2150000
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
782000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-121947000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-75838000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
23873000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
18829000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
6059000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
6350000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3224000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1497000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
505241000
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
300000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-531949000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-23982000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-576000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
281000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-385344000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
286258000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
848565000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
240069000
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
463221000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
526327000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
20180000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
26310000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
277000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1449000
us-gaap Share Repurchase Program Excise Tax
ShareRepurchaseProgramExciseTax
5202000
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1929706000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
135870000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3135000
CY2023Q1 us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
95012
CY2023Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
2000
CY2023Q1 us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
32594
CY2023Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
6350000
CY2023Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
28840
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1028000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1753000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
2065144000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
164400000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3751000
CY2023Q2 us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
18768
CY2023Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
4762
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
468000
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
4283000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
2238046000
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
2563655000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
152381000
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5127000
CY2024Q1 us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
51236
CY2024Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
1000
CY2024Q1 us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
14965
CY2024Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
6059000
CY2024Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
5757
CY2024Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1020000
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-4092000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
2712033000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
150723000
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4632000
CY2024Q2 us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
2022
CY2024Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
1000
CY2024Q2 bld Treasury Stock Shares Acquired Cost Method Share Repurchase Program
TreasuryStockSharesAcquiredCostMethodShareRepurchaseProgram
1246182
CY2024Q2 bld Treasury Stock Value Acquired Cost Method Share Repurchase Program
TreasuryStockValueAcquiredCostMethodShareRepurchaseProgram
510443000
CY2024Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
10269
CY2024Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2204000
CY2024Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1836000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
2357314000
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1365612000
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1317262000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2644329000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2582500000
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1365612000
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1317262000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2644329000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2582500000
CY2024Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
385800000
us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Explanation
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation
over the next 18 months
us-gaap Number Of Reporting Units
NumberOfReportingUnits
2
CY2023Q4 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2023Q4 us-gaap Goodwill Gross
GoodwillGross
2804589000
us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
50294000
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-2074000
CY2024Q2 us-gaap Goodwill Gross
GoodwillGross
2852809000
CY2024Q2 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
762021000
CY2024Q2 us-gaap Goodwill
Goodwill
2090788000
CY2024Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
854873000
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
827793000
CY2024Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
271732000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
236735000
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
583141000
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
591058000
CY2024Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
17947000
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
17211000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
35633000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
34107000
CY2024Q2 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
13031000
CY2023Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
14472000
CY2024Q2 us-gaap Long Term Debt
LongTermDebt
1397634000
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
1420067000
CY2024Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
45665000
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
47039000
CY2024Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1351969000
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1373028000
CY2024Q2 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
23165000
CY2024Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
48750000
CY2024Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
438750000
CY2024Q2 bld Long Term Debt Maturities Repayments Of Principal After Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour
900000000
CY2024Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1410665000
bld Debt Instrument Covenant Net Leverage Ratio
DebtInstrumentCovenantNetLeverageRatio
3.50
bld Debt Instrument Covenant Minimum Interest Coverage Ratio
DebtInstrumentCovenantMinimumInterestCoverageRatio
3.00
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1365612000
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1317262000
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
210392000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
237103000
CY2024Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-7218000
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-13953000
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
203174000
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
223150000
us-gaap Operating Income Loss
OperatingIncomeLoss
424900000
us-gaap Operating Income Loss
OperatingIncomeLoss
436534000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-14731000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-30069000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
410169000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
406465000
bld Business Combination Termination Fee
BusinessCombinationTerminationFee
23000000.0
CY2024Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.258
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.261
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.263
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.261
bld Share Based Payment Arrangement Expense Tax Expense
ShareBasedPaymentArrangementExpenseTaxExpense
2100000
bld Share Based Payment Arrangement Expense Tax Expense
ShareBasedPaymentArrangementExpenseTaxExpense
200000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
150723000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
164400000
us-gaap Net Income Loss
NetIncomeLoss
303104000
us-gaap Net Income Loss
NetIncomeLoss
300270000
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31324833
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31599744
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31483144
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31575337
CY2024Q2 bld Incremental Common Shares Attributable To Dilutive Effect Of Stock Options
IncrementalCommonSharesAttributableToDilutiveEffectOfStockOptions
91516
CY2023Q2 bld Incremental Common Shares Attributable To Dilutive Effect Of Stock Options
IncrementalCommonSharesAttributableToDilutiveEffectOfStockOptions
84998
bld Incremental Common Shares Attributable To Dilutive Effect Of Stock Options
IncrementalCommonSharesAttributableToDilutiveEffectOfStockOptions
93332
bld Incremental Common Shares Attributable To Dilutive Effect Of Stock Options
IncrementalCommonSharesAttributableToDilutiveEffectOfStockOptions
85522
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31524063
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31731807
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31693524
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31722660
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.81
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
5.20
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
9.63
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
9.51
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.78
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
5.18
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
9.56
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
9.47
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
14801
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
28590
CY2024Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4632000
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3751000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9759000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6886000
CY2024Q2 bld Share Based Payment Arrangement Expense Tax Expense
ShareBasedPaymentArrangementExpenseTaxExpense
98000
CY2023Q2 bld Share Based Payment Arrangement Expense Tax Expense
ShareBasedPaymentArrangementExpenseTaxExpense
180000
bld Share Based Payment Arrangement Expense Tax Expense
ShareBasedPaymentArrangementExpenseTaxExpense
2107000
bld Share Based Payment Arrangement Expense Tax Expense
ShareBasedPaymentArrangementExpenseTaxExpense
225000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P4Y8M12D
bld Schedule Of Unrecognized Share Based Compensation Expense Nonvested Awards
ScheduleOfUnrecognizedShareBasedCompensationExpenseNonvestedAwards
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt;">We have unrecognized share-based compensation expense related to unvested awards as shown in the following table, dollars in thousands:</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:59.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:17.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:17.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:59.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:9pt;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:38.78%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-weight:bold;">As of June 30, 2024</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:59.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:9pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;width:18.62%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-weight:bold;">Unrecognized Compensation Expense </b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">on Unvested Awards</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;width:18.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-weight:bold;">Weighted Average</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Remaining</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Compensation Expense Period</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:59.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;margin:0pt 0pt 0pt 12pt;">RSAs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;text-align:right;margin:0pt 3pt 0pt 0pt;"> 27,675</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:right;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:center;margin:0pt;"><span style="font-size:9pt;"> 1.1</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:59.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;margin:0pt 0pt 0pt 12pt;">Stock options</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;text-align:right;margin:0pt 3pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:right;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;text-align:center;margin:0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:59.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;margin:0pt;">Total unrecognized compensation expense related to unvested awards</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.1%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;text-align:right;margin:0pt 3pt 0pt 0pt;"> 27,675</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:right;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:right;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td></tr></table>
CY2024Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
27675000
CY2024Q2 us-gaap Share Repurchase Program Excise Tax Payable
ShareRepurchaseProgramExciseTaxPayable
5200000
CY2023 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
1246182
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
510443000
us-gaap Share Repurchase Program Excise Tax
ShareRepurchaseProgramExciseTax
5200000
CY2024Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
26300000
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
26800000
CY2023Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
1100000
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
2800000
CY2024Q2 us-gaap Business Acquisition Purchase Price Allocation Goodwill Expected Tax Deductible Amount
BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
50300000
CY2023Q2 us-gaap Business Acquisition Purchase Price Allocation Goodwill Expected Tax Deductible Amount
BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
23100000
CY2024Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
62862000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
67471000
CY2024Q2 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
31417000
CY2023Q4 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
29920000
CY2024Q2 bld Accrued Sales Property And Excise Taxes Current
AccruedSalesPropertyAndExciseTaxesCurrent
21206000
CY2023Q4 bld Accrued Sales Property And Excise Taxes Current
AccruedSalesPropertyAndExciseTaxesCurrent
17002000
CY2024Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
15981000
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
18365000
CY2024Q2 bld Accrued Customer Rebates Current
AccruedCustomerRebatesCurrent
12306000
CY2023Q4 bld Accrued Customer Rebates Current
AccruedCustomerRebatesCurrent
17326000
CY2024Q2 us-gaap Interest Payable Current
InterestPayableCurrent
12138000
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
12139000
CY2024Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
20843000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
24994000
CY2024Q2 bld Accrued Liabilities And Employee Related Liabilities Current
AccruedLiabilitiesAndEmployeeRelatedLiabilitiesCurrent
176753000
CY2023Q4 bld Accrued Liabilities And Employee Related Liabilities Current
AccruedLiabilitiesAndEmployeeRelatedLiabilitiesCurrent
187217000
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001558370-24-011080-index-headers.html Edgar Link pending
0001558370-24-011080-index.html Edgar Link pending
0001558370-24-011080.txt Edgar Link pending
0001558370-24-011080-xbrl.zip Edgar Link pending
bld-20240630.xsd Edgar Link pending
bld-20240630x10q.htm Edgar Link pending
bld-20240630xex31d1.htm Edgar Link pending
bld-20240630xex31d2.htm Edgar Link pending
bld-20240630xex32d1.htm Edgar Link pending
bld-20240630xex32d2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
bld-20240630_cal.xml Edgar Link unprocessable
bld-20240630_def.xml Edgar Link unprocessable
bld-20240630_lab.xml Edgar Link unprocessable
bld-20240630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
bld-20240630x10q_htm.xml Edgar Link completed
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending